Clinical Trial Update: Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cyclosporine inhalation solution for bronchiolitis obliterans syndrome in lung transplant and hematopoietic stem cell transplant recipi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans Syndrome
• Constrictive Bronchiolitis

Drugs mentioned

• Cyclosporine Inhalation Solution (cyclosporine)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Constrictive Bronchiolitis, Bronchiolitis Obliterans | Phase 2 | Status: COMPLETED | Results posted: 2020-09-24